Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report
Maocai Tang
Chongqing University Cancer Hospital
The Comparative Study of Indocyanine Green and Carbon Nanoparticle Suspension Injection for Lymph Node Tracing in Laparoscopic Radical Gastrectomy for Gastric Cancer
Masood A Shammas
Dana Farber Cancer Institute
Apurinic/apyrimidinic nuclease 1 drives genomic evolution contributing to chemoresistance and tumorigenesis in cancer
Veronika Nemethova
Comenius University Bratislava
An unconventional therapeutic oligonucleotide effectively eliminates TKI-resistant CML cells
Richard G Pestell
Baruch S Blumberg Institute
The humanized monoclonal ant-CCR5 antibody blocks breast cancer cellular metastasis and enhances cell death induced by DNA-damaging chemotherapy
Jan Dominik Kuhlmann
Technische Universität Dresden
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of CtDNA